Company Press Release

The injectables will adhere to GS1 standards.

The Series A funding is led by Thrive Capital.

The platform will focus on aesthetic medicine practices in North America.

The surgery occurred at Tangerang Hospital in Indonesia.

The session will focus on leveraging AI for good.

Dr. Bonham joins as chief pathologist and executive medical director.

The patch provides real time monitoring for remote patients.

The partnership will focus on developing Lunit's SCOPE, an AI biomarker platform.

The updates will be implemented on the Eureka Clinical AI platform.

The platform will accelerate cell therapy discovery, development, and manufacturing.

The software, named Health Verity FLOW, will integrate data from real-world examples, clinical trials, and other registries for pharmaceutical manufacturers.

If certified, Tasso would be able to offer its services to additional markets.

The two companies will work together to create digital twins to fight the cancer.

The U.S. Department of Defense awarded the contract with the goal of developing and providing a device that can be used in the field.

The platform, called Target Discovery, allows for more efficient discovery and information retrieval.

The move will increase the firm's presence in Germany, Austrian, and Switzerland.

The platform connects cancer patients with potential treatment options.

The software is based on medical imaging technology.

The company is teaming up with Singapore's Institute for Clinical Sciences on the initiative.

The healthcare technology company is working with Saitama Medical University Hospital in Japan on the trial.

HDPCR technology assists laboratories cataloging biomarkers.

The wearable tech company is partnering with the veteran and active military personal focused company.

GlobalData, a data and analytics company, released its findings in a new report.

The partnership will allow Sygnature Discovery to provide virtual high throughput screening expertise, among other services, to Daewoong Pharma's projects.

The partnership is called CancerX and comes in response to the White House Cancer Moonshot.

The company is seeking to sell its assets through the sales process.

Schaefer previously worked at Takeda as senior vice president of the neuroscience business unit and head of commercial operations in the U.S.

Edwards took over the role on April 1, 2023.

Datacubed Health is a technology company focused on making clinical trials more efficient.

The two companies will collaborate to develop and commercialize integrated diabetes self-management solutions.